Standout Papers

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer 2018 2026 2020 2023 2.9k
  1. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer (2018)
    Peter Schmid, Sylvia Adams et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 11 from Science/Nature 51 standout
Sub-graph 1 of 24

Citing Papers

Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
2025 Standout
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
2025 Standout

Works of Gail S. Wright being referenced

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout

Author Peers

Author Last Decade Papers Cites
Gail S. Wright 2639 1078 62 889 19 3.5k
Volkmar Henschel 3884 1835 100 1242 42 5.3k
Peter Savas 3122 959 22 1651 49 4.2k
Gursel Aktan 2486 835 19 726 52 3.0k
Kun He 1955 1223 13 563 53 3.1k
Viswam S. Nair 1457 1101 19 1258 43 3.3k
Laurence Buisseret 2535 654 15 1596 64 3.5k
Anushka Dongre 1703 470 62 750 14 3.6k
Ariel López-Chávez 2711 1853 21 562 41 3.6k
Shijun Kang 1964 836 35 1159 22 2.9k
Daniela S. Thommen 3088 659 21 2442 37 4.3k

All Works

Loading papers...

Rankless by CCL
2026